About RD-Biotech
RD-Biotech is a Healthcare company based in Besancon (France) founded in 2002. It operates as a monoclonal antibodies, plasmids, and recombinant proteins are developed and produced. RD-Biotech offers products and services including Anticorps monoclonaux, Anticorps recombinants, ADN Plasmides, Culture cellulaire, and Protéines recombinantes. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its competitors include Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
RD-Biotech was established in 2002 in Besancon, France, within the biotechnology sector. Monoclonal antibodies are developed and produced, alongside plasmids, recombinant antibodies, and cell lines. Operations encompass plasmid preparation and custom services, including RNA vector construction, recombinant protein expression and purification, monoclonal antibody sequencing, in-vitro transcription, PCR, and real-time PCR. These activities support research and development needs in the field.
- Headquarters Besancon, France
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website rd-biotech.com
- Social LinkedIn X Facebook YouTube
Products & Services of RD-Biotech
RD-Biotech offers a comprehensive portfolio of products and services, including Anticorps monoclonaux, Anticorps recombinants, ADN Plasmides, Culture cellulaire, and Protéines recombinantes.
Development and production of monoclonal antibodies for research.
Expression and purification of recombinant antibodies for applications.
Production of DNA plasmids for R&D and GMP-like grades.
Cell production and banking services for preclinical use.
Expression of recombinant proteins in various systems.
Development of analytical methods like immunoassays.
Ready-to-use ELISA kits for rapid result detection.
Apps and channels of RD-Biotech
its YouTube channel RD-BIOTECH has 9 subscribers and 10 videos.
Videos from RD-Biotech
The most watched videos on RD-Biotech's YouTube channel, RD-BIOTECH (9 subscribers). Click a video to play it here.
More on RD-BIOTECH.
Competitors of RD-Biotech
RD-Biotech has 10 listed competitors in our database, 7 of them funded. They include Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| solexa.com | 1992 | Hayward, United States | $14.4M | – | Develops Genome sequencing technology | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of RD-Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RD-Biotech
The website of RD-Biotech (rd-biotech.com) receives about 1.7K visits a month and ranks #11,064,917 among all websites worldwide, #8,041 in Biotechnology and Pharmaceuticals.
- Monthly visits1.7K
▲ 48.2% vs previous month
- Global rank#11,064,917
among all websites
- Category rank#8,041
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit2.3
- Average visit45 sec
- DevicesDesktop 59% · Mobile 41%
Websites whose visitors overlap most with RD-Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fapon.com | fapon.com | 100% | – | – | – |
| syngeneintl.com | 100% | 94K | #525,515 | View details | |
| avidbio.com | 100% | 12.3K | #1,697,368 | View details | |
| covance.com | 100% | 20.2K | #688,229 | View details | |
| bioreliance.com | 100% | 2.1K | #7,984,772 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for RD-Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as RD-Biotech (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rd-Biotech
Complete news archive for RD-Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RD-Biotech
RD-Biotech was founded in 2002.
RD-Biotech is headquartered in Besancon, France.
RD-Biotech was established in 2002 in Besancon, France, within the biotechnology sector. Monoclonal antibodies are developed and produced, alongside plasmids, recombinant antibodies, and cell lines. Operations encompass plasmid preparation and custom services, including RNA vector construction, recombinant protein expression and purification, monoclonal antibody sequencing, in-vitro transcription, PCR, and real-time PCR. These activities support research and development needs in the field.
RD-Biotech's top competitors include Novogene Corporation, BGI and Source BioScience.
RD-Biotech offers Anticorps monoclonaux, Anticorps recombinants, ADN Plasmides, Culture cellulaire, and 3 more products and services.